Knowles MA - Search Results

1

Prevalence of 9p21 deletions in UK melanoma families.

Mistry SH, Taylor C, Randerson-Moor JA, Harland M, Turner F, Barrett JH, Whitaker L, Jenkins RB, Knowles MA, Bishop JA, Bishop DT. Mistry SH, et al. Among authors: knowles ma. Genes Chromosomes Cancer. 2005 Nov;44(3):292-300. doi: 10.1002/gcc.20238. Genes Chromosomes Cancer. 2005. PMID: 16032697

2

Somatic mutation of PTEN in bladder carcinoma.

Aveyard JS, Skilleter A, Habuchi T, Knowles MA. Aveyard JS, et al. Among authors: knowles ma. Br J Cancer. 1999 May;80(5-6):904-8. doi: 10.1038/sj.bjc.6690439. Br J Cancer. 1999. PMID: 10360673 Free PMC article.

3

Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer.

Nishiyama H, Takahashi T, Kakehi Y, Habuchi T, Knowles MA. Nishiyama H, et al. Among authors: knowles ma. Genes Chromosomes Cancer. 1999 Oct;26(2):171-5. Genes Chromosomes Cancer. 1999. PMID: 10469456

4

A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family.

Randerson-Moor JA, Harland M, Williams S, Cuthbert-Heavens D, Sheridan E, Aveyard J, Sibley K, Whitaker L, Knowles M, Bishop JN, Bishop DT. Randerson-Moor JA, et al. Hum Mol Genet. 2001 Jan 1;10(1):55-62. doi: 10.1093/hmg/10.1.55. Hum Mol Genet. 2001. PMID: 11136714

5

Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines.

Williams SV, Sibley KD, Davies AM, Nishiyama H, Hornigold N, Coulter J, Kennedy WJ, Skilleter A, Habuchi T, Knowles MA. Williams SV, et al. Among authors: knowles ma. Genes Chromosomes Cancer. 2002 May;34(1):86-96. doi: 10.1002/gcc.10050. Genes Chromosomes Cancer. 2002. PMID: 11921286

6

Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder.

Knowles MA, Habuchi T, Kennedy W, Cuthbert-Heavens D. Knowles MA, et al. Cancer Res. 2003 Nov 15;63(22):7652-6. Cancer Res. 2003. PMID: 14633685

7

High-resolution deletion mapping of 15q13.2-q21.1 in transitional cell carcinoma of the bladder.

Natrajan R, Louhelainen J, Williams S, Laye J, Knowles MA. Natrajan R, et al. Among authors: knowles ma. Cancer Res. 2003 Nov 15;63(22):7657-62. Cancer Res. 2003. PMID: 14633686

8

Measurement of relative copy number of CDKN2A/ARF and CDKN2B in bladder cancer by real-time quantitative PCR and multiplex ligation-dependent probe amplification.

Aveyard JS, Knowles MA. Aveyard JS, et al. Among authors: knowles ma. J Mol Diagn. 2004 Nov;6(4):356-65. doi: 10.1016/S1525-1578(10)60532-6. J Mol Diagn. 2004. PMID: 15507675 Free PMC article.

9

Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss.

Adams J, Williams SV, Aveyard JS, Knowles MA. Adams J, et al. Among authors: knowles ma. Cancer Res. 2005 Jan 1;65(1):66-75. Cancer Res. 2005. PMID: 15665280

10

Association between hormonal genetic polymorphisms and early-onset prostate cancer.

Forrest MS, Edwards SM, Houlston R, Kote-Jarai Z, Key T, Allen N, Knowles MA, Turner F, Ardern-Jones A, Murkin A, Williams S, Oram R, Bishop DT, Eeles RA; CR-UK/BPG UK prostate cancer study collaborators. Forrest MS, et al. Among authors: knowles ma. Prostate Cancer Prostatic Dis. 2005;8(1):95-102. doi: 10.1038/sj.pcan.4500785. Prostate Cancer Prostatic Dis. 2005. PMID: 15711606

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

236 results

Search Page